Comparison

Nicodicosapent European Partner

Item no. HY-17640-2mg
Manufacturer MedChem Express
CASRN 1269181-69-2
Amount 2 mg
Quantity options 100 mg 10mM/1mL 10 mg 2 mg 50 mg 5 mg
Category
Type Inhibitors
Specific against other
Purity 99.79
Formula C28H39N3O2
Citations [1]Vu CB, et al. Synthesis and Characterization of Fatty Acid Conjugates of Niacin and Salicylic Acid. J Med Chem. 2016 Feb 11;59(3):1217-31.
Smiles O=C(C1=CC=CN=C1)NCCNC(CCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)=O
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias 1269181-69-2
Shipping Condition Cool pack
Available
Manufacturer - Type
Reference compound
Manufacturer - Applications
Metabolism-sugar/lipid metabolism
Manufacturer - Targets
Autophagy; Fatty Acid Synthase (FASN)
Shipping Temperature
Blue Ice
Storage Conditions
-20°C (Powder, stored under nitrogen)
Molecular Weight
449.63
Product Description
Nicodicosapent is a fatty acid niacin conjugate that is also an inhibitor of the sterol regulatory element binding protein (SREBP), a key regulator of cholesterol metabolism proteins such as PCSK9, HMG-CoA reductase, ATP citrate lyase, and NPC1L1.
Manufacturer - Research Area
Metabolic Disease
Solubility
DMSO : ≥ 100 mg/mL|Ethanol : 3.33 mg/mL (ultrasonic)
Manufacturer - Pathway
Autophagy; Metabolic Enzyme/Protease
Clinical information
No Development Reported

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 2 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close